Back to search results

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8 · Anatomic Stage IB Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Early Stage Triple-Negative Breast Carcinoma · Locally Advanced Triple-Negative Breast Carcinoma · Metastatic Triple-Negative Breast Carcinoma · Prognostic Stage I Breast Cancer AJCC v8 · Prognostic Stage IA Breast Cancer AJCC v8 · Prognostic Stage IB Breast Cancer AJCC v8 · Prognostic Stage II Breast Cancer AJCC v8 · Prognostic Stage IIA Breast Cancer AJCC v8 · Prognostic Stage IIB Breast Cancer AJCC v8 · Prognostic Stage III Breast Cancer AJCC v8 · Prognostic Stage IIIA Breast Cancer AJCC v8 · Prognostic Stage IIIB Breast Cancer AJCC v8 · Prognostic Stage IIIC Breast Cancer AJCC v8 · Prognostic Stage IV Breast Cancer AJCC v8 · Recurrent Breast Carcinoma · Unresectable Triple-Negative Breast Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Grady Health System, Atlanta, Georgia, United States

    Contact: Study coordinator (Deborah Omoyege) · deborah.omoyege@emory.edu
    Contact: Principal Investigator (Keerthi Gogineni, MD, MSHP)

  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Deborah Omoyege) · deborah.omoyege@emory.edu
    Contact: Principal Investigator (Keerthi Gogineni, MD, MSHP)

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Deborah Omoyege) · deborah.omoyege@emory.edu
    Contact: Principal Investigator (Keerthi Gogineni, MD, MSHP)

  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Deborah Omoyege) · deborah.omoyege@emory.edu
    Contact: Principal Investigator (Keerthi Gogineni, MD, MSHP)
Study leads

  • Keerthi Gogineni, MD, MSHP

    Principal Investigator

    Emory University Hospital/Winship Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)